Antiviral Drug Strategies (Methods and Principles in Medicinal Chemistry) - nieuw boek

EAN (ISBN-13): 9783527326969
ISBN (ISBN-10): 3527326960
Gebonden uitgave
Verschijningsjaar: 2011
Uitgever: Wiley-VCH
406 Bladzijden
Gewicht: 0,946 kg
Taal: eng/Englisch

Boek bevindt zich in het datenbestand sinds 2008-06-20T09:28:49+02:00 (Amsterdam)
Detailpagina laatst gewijzigd op 2023-01-27T22:40:15+01:00 (Amsterdam)
ISBN/EAN: 3527326960

ISBN - alternatieve schrijfwijzen:
3-527-32696-0, 978-3-527-32696-9
alternatieve schrijfwijzen en verwante zoekwoorden:
Auteur van het boek: clercq, kubinyi, clerc, hugo, wiley vch, gerd folkers
Titel van het boek: principles chemistry

---

Gegevens van de uitgever

Auteur: Erik De Clercq
Titel: Methods and Principles in Medicinal Chemistry; Antiviral Drug Strategies
Uitgeverij: Wiley-VCH; Wiley-VCH
406 Bladzijden
Verschijningsjaar: 2011-04-06
Gedrukt / Gemaakt in
Gewicht: 0,970 kg
Taal: Engels
195,00 € (DE)
Not available (reason unspecified)
170mm x 240mm x 26mm

BB; Hardcover, Softcover / Chemie; Medizinische Chemie, Pharmazeutische Chemie; Verstehen; Chemie; Biowissenschaften; Chemie; Chemistry; Drug Discovery & Development; Life Sciences; Virologie; Virology; Wirkstoffforschung; Wirkstoffforschung u. -entwicklung; Wirkstoffforschung u. -entwicklung; Virologie

New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need to be cut short. This is only possible by relying on proven strategies and adapting them to the specific features of any new virus or virus variant. By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It is edited by Erik de Clercq, a world authority on antiviral drug discovery. The volume covers a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases, and primases, as well as their known inhibitors. The book also contains several case studies of recent successful antiviral drug development. As a result, medicinal and pharmaceutical chemists, as well as virologists will be able to pinpoint strategies for combating future viral pandemics.